Shares of Nabriva Therapeutics PLC – (NASDAQ:NBRV) have been given an average rating of “Buy” by the nine ratings firms that are presently covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and seven have assigned a buy recommendation to the company. […]
